Cronos Group Inc.
CRON | NASDAQ
$3.42
+$0.09 (+2.70%)
Sep 22, 2026, 2:47 PM ET · Market open
Company Profile
Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption. Its cannabis offerings encompass dried flower, pre-rolled joints, edibles, concentrates, and various extracts, which are distributed via wholesale channels and directly to clients. The wellness segment operates under the PEACE NATURALS platform, while its adult-use products are marketed through the Spinach brand. Additionally, Cronos exports dried cannabis and cannabis oils to international markets such as Germany, Israel, and Australia. Founded in 2012, the company's headquarters are located in Toronto, Canada.
Key Executives
| Name | Position |
|---|---|
| Michael Ryan Gorenstein | President, Chief Executive Officer & Chairman |
| Anna Shlimak | Chief Financial Officer |
| Adam Wagner | General Manager of Cronos Israel |
| Arye Weigensberg | Senior Vice President and Head of Research & Development |
| Harrison Aaron | Senior Director of Investor Relations & Corporate Development |
| Jared Matthew Kenost | Principal Accounting Officer, Vice President & Controller |
| Jeffrey David Jacobson | Chief Growth Officer |
| Shannon Buggy | Senior Vice President & Global Head of People |
| Terry Gregory-Joseph Doucet | General Counsel & Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 07, 2026 | 4 | Filing |
| Aug 07, 2026 | 4 | Filing |
| Aug 07, 2026 | 4 | Filing |
| Aug 07, 2026 | 8-K/A | [Amend] Current Report |
| Aug 06, 2026 | 10-Q | Quarterly Report |
| Aug 06, 2026 | 8-K | Current Report |
| Jun 30, 2026 | 3 | Filing |
| Jun 22, 2026 | 8-K | Current Report |
| May 29, 2026 | SD | Filing |
| May 14, 2026 | 4 | Filing |
Cronos Group Inc.
| Country | Canada |
| IPO Date | Feb 26, 2018 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 610 |
| CEO | Michael Ryan Gorenstein |
Contact Details
4491 Concession Road 12 Stayner,
ON L0M 1S0 Canada
Stock Details
| Ticker Symbol | CRON |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001656472 |
| CUSIP Number | 22717L101 |
| ISIN Number | CA22717L1013 |
| SIC Code | 2833 |
Recent News
- 7 days ago / seekingalpha.comCronos: Invest In Cannabis With 50% Net Cash And GAAP Profitability
- 7 days ago / globenewswire.comCronos to Host 2026 Investor Day at its Cronos GrowCo Facility in Kingsville, Ontario
- 20 days ago / zacks.comAre Medical Stocks Lagging Cronos Group (CRON) This Year?
- 20 days ago / globenewswire.comCronos' brand Spinach® Expands its Best-Selling Lineups of Edibles and Vapes
- 1 month ago / zacks.comSurging Earnings Estimates Signal Upside for Cronos (CRON) Stock
- 2 months ago / seekingalpha.comCronos Group: This Cannabis Name Isn't Reliant On U.S. Legalization Efforts
- 2 months ago / seekingalpha.comCronos: Strong Quarter, And The Outlook For The Future Is Positive Thanks To M&A
- 2 months ago / marketbeat.comCronos Group Q2 Earnings Call Highlights
- 2 months ago / globenewswire.comCronos Group Reports 2026 Second Quarter Results
- 2 months ago / marijuanastocks.com3 Top Canadian Marijuana Stock Picks To Add Value To Your Portfolio
Add to Watchlist
Select watchlists to add or remove CRON